Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mark A Fletcher

6PUBLICATIONS

32CO-AUTHORS

Disease surveillanceMedical infection agents (incl. prions)Major global burdens of diseasePhysical education and development curriculum and pedagogyPanel data analysis

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Oct 27, 2025

Respiratory Syncytial Virus Infection in Older Adults in Asia: A Modified Delphi Expert Consensus on Surveillance, Diagnosis, and Prevention.

Yu-Jiun Chan, Philip Eng, Pin-Kuei Fu

|Apr 26, 2025

Correction: Méroc et al. Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine. <i>Microorganisms</i> 2023, <i>11</i>, 1816.

Estelle Méroc, Mark A Fletcher, Germaine Hanquet

|Jul 29, 2023

Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine.

Estelle Méroc, Mark A Fletcher, Germaine Hanquet

|May 28, 2022

Correction: Theilacker et al. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). <i>Microorganisms</i> 2022, <i>10</i>, 127.

Christian Theilacker, Mark A Fletcher, Luis Jodar

|Sep 27, 2021

Letter to the editor regarding "Budget impact analysis of pneumococcal conjugate vaccines in Colombia".

Juan M Reyes, Jorge LaRotta, Natalia Castano

|Jun 10, 2020

Diabetes mellitus as a vaccine-effect modifier: a review.

Thomas Verstraeten, Mark A Fletcher, Jose A Suaya

Pageof 1

Frequent Collaborators

2 joint publications

Kyla Hayford

2 joint publications

Lindsay R Grant

2 joint publications

Marc Baay

2 joint publications

Mary P E Slack

2 joint publications

Estelle Méroc

1 joint publications

Jose A Suaya

1 joint publications

Sally Jackson

1 joint publications

Daniel A Scott

1 joint publications

Beate Schmöle-Thoma

1 joint publications

Juan M Reyes

Frequent Collaborators

2 joint publications

Kyla Hayford

2 joint publications

Lindsay R Grant

2 joint publications

Marc Baay

2 joint publications

Mary P E Slack

Top Related Videos

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on : Jan 26, 2019

Constructing Mutants in Serotype 1 <em>Streptococcus pneumoniae</em> strain 519/43

Constructing Mutants in Serotype 1 <em>Streptococcus pneumoniae</em> strain 519/43

Published on : Sep 11, 2020

See more related videos

Top Related Videos

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on : Jan 26, 2019

Constructing Mutants in Serotype 1 <em>Streptococcus pneumoniae</em> strain 519/43

Constructing Mutants in Serotype 1 <em>Streptococcus pneumoniae</em> strain 519/43

Published on : Sep 11, 2020

See more related videos